Search results for: 'development startup and future trend of ophthalmic drugs market'

This Frost & Sullivan study analyzes Trend Opportunity Profiles that envision the Future of Work from a technology perspective; it covers advanced technologies incorporated in the work culture, and it features upcoming trends that cater to the futuristic needs of the workplace. The study also describes opportunities for several sectors, including b...

The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

Countries across the world have adopted several transformative work trends. This study analyzes how those trends create a better work environment and generate opportunities for major sectors, such as technology, energy, industrial, mobility, business and financial services, agriculture, security, aerospace and defense, supply chain and logistics, r...

In this report, Frost & Sullivan covers construction's global and future aspects, focusing on upcoming trends. The study details opportunities for mobility, industrial, fast-moving consumer goods (FMCG), retail, information and communications technology (ICT), business and financial services, and supply chain and logistics. It offers industry sta...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...

Frost & Sullivan’s Trend Opportunity Profiles are designed to help clients discover and prioritize the most consequential mid-to-long term trends transforming their business growth environment. To create each profile, Frost & Sullivan analyzes the trend opportunity across key industries, including aerospace and defense; health, wellness, and well-b...

This research service overviews the global ADC market and provides a 6-year revenue forecast from 2023 to 2028. An ADC comprises multiple components such as the antibody, conjugation chemistry, linker, and payload. Many companies are working on each component while others only develop ADCs, which makes the market highly competitive. The development...